The peroxisome proliferator-activated receptor α (PPARα):: role in hepatocarcinogenesis

被引:55
|
作者
Gonzalez, FJ [1 ]
机构
[1] NCI, NIH, Bethesda, MD 20892 USA
关键词
peroxisome proliferators; PPAR alpha; apoptosis; oxidative stress; hepatocarcinogenesis; Kupffer cells; cytokines;
D O I
10.1016/S0303-7207(02)00098-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The peroxisome proliferator-activated receptor alpha (PPARalpha) is a member of the nuclear receptor superfamily and mediates most of the known biological effects of peroxisome proliferators. The latter represents a large group of chemicals that include the fibrate hyperlipidemic drugs, the pthalate plasticizers, various solvents and degreasing agents, and endogenous hormones and fatty acids. Peroxisome proliferators are classical members of the nongenotoxic group of chemical carcinogens that do not require metabolic activation to electrophiles in order to exert their harmful effects. These chemicals are of particular concern to regulatory agencies since they can only be detected by long-term carcinogen bioassays using rodents. The mechanism of the carcinogenic action of peroxisome proliferators is beginning to emerge. PPARalpha-null mice are resistant to hepatocarcinogenesis indicating that this receptor is necessary for cancer. However, recent studies indicate that Kupffer cells, in a PPARalpha independent manor, are required for the major effects of peroxisome proliferators on cell proliferation. An interaction between PPARalpha and estrogen carcinogenesis has also been elucidated. (C) 2002 Published by Elsevier Science Ireland Ltd.
引用
收藏
页码:71 / 79
页数:9
相关论文
共 50 条
  • [21] STRUCTURE, FUNCTION AND ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA - PPARγ
    Mrowka, Piotr
    Glodkowska-Mrowka, Eliza
    POSTEPY BIOLOGII KOMORKI, 2011, 38 (04) : 629 - 651
  • [22] The role of the peroxisome proliferator-activated receptor α (PPARα) in the control of cardiac lipid metabolism
    Djouadi, F
    Brandt, JM
    Weinheimer, CJ
    Leone, TC
    Gonzalez, FJ
    Kelly, DP
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1999, 60 (5-6): : 339 - 343
  • [23] The role of peroxisome proliferator-activated receptor (PPAR)-r? ligands in platelet activation
    Han, J-Y
    Choi, J. L.
    Kim, B. R.
    Goh, R-Y
    Park, J-, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 898 - 898
  • [24] Prostaglandins are weak ligands of the peroxisome proliferator-activated receptor γ (PPARγ).
    Ferry, G
    Bruneau, V
    Beauverger, P
    Goussard, M
    Rodriguez, M
    Levens, N
    Galizzi, JP
    Boutin, JA
    FASEB JOURNAL, 2000, 14 (08): : A1441 - A1441
  • [25] Differential splicing of the human peroxisome proliferator-activated receptor, PPARβ/δ
    Su, Shengzhong
    Omiecinski, Curtis J.
    FASEB JOURNAL, 2007, 21 (05): : A419 - A419
  • [26] Role of peroxisome proliferator-activated receptor α in atherosclerosis
    Cao, Heng
    Wen, Gao
    Li, Hongli
    MOLECULAR MEDICINE REPORTS, 2014, 9 (05) : 1755 - 1760
  • [27] Peroxisome proliferator-activated receptor (PPAR) modulators: Diabetes and beyond
    Jones, AB
    MEDICINAL RESEARCH REVIEWS, 2001, 21 (06) : 540 - 552
  • [28] Natural Peroxisome Proliferator-Activated Receptor γ (PPARγ) Activators for Diabetes
    Abdallah, Hossam M.
    El Dine, Riham Salah
    Mohamed, Gamal A.
    Ibrahim, Sabrin R. M.
    Shehata, Ibrahim A.
    El-Halawany, Ali M.
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2020, 26 : 28 - 44
  • [29] The role of peroxisome proliferator-activated receptors (PPAR) in immune responses
    Christofides, Anthos
    Konstantinidou, Eirini
    Jani, Chinmay
    Boussiotis, Vassiliki A.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 114
  • [30] Role of peroxisome proliferator-activated receptor alpha (PPARα) in human intrahepatic lipid metabolism
    Vuppalanchi, R
    Kolwankar, D
    Marri, SR
    Skaar, T
    Chalasani, NP
    Jones, DR
    Hall, SD
    DRUG METABOLISM REVIEWS, 2004, 36 : 315 - 315